Stockscreener 앱 받기
206.23
1.01%
-2.11
시간 외 거래:
206.30
0.07
+0.03%
Abbvie Inc 주식(ABBV)의 최신 뉴스
Buy Or Fear AbbVie Stock At $210? - Forbes
What’s Happening With AbbVie Stock? - Trefis
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie - Benzinga
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie - Benzinga
Stillwater Wealth Management Group Takes Position in AbbVie Inc. $ABBV - MarketBeat
Groupama Asset Managment Purchases 10,854 Shares of AbbVie Inc. $ABBV - MarketBeat
Investment Research Partners LLC Buys New Shares in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by CIBC Private Wealth Group LLC - MarketBeat
243,718 Shares in AbbVie Inc. $ABBV Bought by CIBC Bancorp USA Inc. - MarketBeat
Centaurus Financial Inc. Has $3.08 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Allworth Financial LP Acquires 30,124 Shares of AbbVie Inc. $ABBV - MarketBeat
Achmea Investment Management B.V. Has $84.36 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. Stock (ISIN: US00287Y1091) Faces Pressure Amid Recent Pullback: Key Drivers and Investor - AD HOC NEWS
Assessing AbbVie (ABBV) Valuation After The Recent Share Price Pullback - Yahoo Finance
What's Going On With AbbVie Stock Today?AbbVie (NYSE:ABBV) - Benzinga
Is AbbVie Inc. (ABBV) one of the debt free halal stocks to buy? - MSN
AbbVie Inc. stock underperforms Wednesday when compared to competitors - MSN
AbbVie (NYSE:ABBV) Trading Down 5.1%Here's Why - MarketBeat
AbbVie (ABBV) Stock Drops 5% After FDA Approves J&J’s Competing Psoriasis Drug - CoinCentral
AbbVie (ABBV) Faces New Competition from J&J's Icotyde Approval - GuruFocus
AbbVie Inc. (ABBV) is attracting investor attention: Here is what you should know - MSN
J&J’s psoriasis pill to rival AbbVie’s Skyrizi (JNJ:NYSE) - Seeking Alpha
AbbVie (ABBV) slides as investors weigh policy-related pricing risk and recent financing activity - Quiver Quantitative
What triggered AbbVie shares' latest price pullback - Traders Union
AbbVie, Philip Morris among market cap stock movers on Wednesday - Investing.com
Weak momentum, oversold signals: AbbVie stock slides 3.70% - Traders Union
AbbVie Inc Stock (ABBV) Moved Down by 4.60% on Mar 18: A Full Analysis - TradingKey
AbbVie Stock: EPS Set to Jump 45% in 2026 as Skyrizi and Rinvoq Dominate IBD - TIKR.com
AbbVie Inc. $ABBV Shares Sold by Wilmington Savings Fund Society FSB - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Sunbelt Securities Inc. - MarketBeat
Danske Bank A S Invests $279.61 Million in AbbVie Inc. $ABBV - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Has $31.89 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Captrust Financial Advisors Boosts Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Balances False Claims Act Risks With Alloy Antibody Collaboration - simplywall.st
Advisory Services Network LLC Trims Holdings in AbbVie Inc. $ABBV - MarketBeat
ABBV Stock Quote Price and Forecast - CNN
AbbVie Inc. (ABBV): Billionaire Ken Fisher admires this pharma stock - MSN
AbbVie Inc. (ABBV): Billionaire Ken Fisher Admires This Pharma Stock - Insider Monkey
AbbVie Slips Below 50-Day SMA: Buy, Sell or Hold the Stock? - TradingView
Alloy Therapeutics and Abbvie partner on antibody platform - BioWorld MedTech
AbbVie Inc. $ABBV Shares Purchased by Mirabella Financial Services LLP - MarketBeat
Mariner LLC Purchases 175,406 Shares of AbbVie Inc. $ABBV - MarketBeat
US FDA declines to approve Aldeyra's eye disorder drug, shares slump - Reuters
Morse Asset Management Inc Grows Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Stock Holdings Trimmed by Mercer Global Advisors Inc. ADV - MarketBeat
AbbVie price tries to vent off oversold saturationForecast today17-03-2026 - Economies.com
Mirabella Financial Services LLP Buys 19,980 Shares of AbbVie Inc. $ABBV - MarketBeat
Moore Capital Management LP Sells 40,000 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Stock Holdings Decreased by L2 Asset Management LLC - MarketBeat
AbbVie (ABBV) Partners with Alloy Therapeutics for Advanced Anti - GuruFocus
Alloy Therapeutics agreement with AbbVie to develop a new antibody platform - marketscreener.com
Alloy Therapeutics Agreement With AbbVie To Develop A New Antibody Platform - TradingView
Alloy Therapeutics Enters Into Agreement to Advance Novel Antibody Discovery Platform - Business Wire
Integrated Wealth Concepts LLC Raises Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Bamco Inc. NY Invests $4.86 Million in AbbVie Inc. $ABBV - MarketBeat
William Blair asserts AbbVie Inc. (ABBV) growth prospects on obesity treatment opportunities - MSN
William Blair Asserts AbbVie Inc. (ABBV) Growth Prospects on Obesity Treatment Opportunities - Yahoo Finance
AbbVie (ABBV) Unveils Skin Quality Index Following Comprehensive Study - GuruFocus
AbbVie’s Allergan Aesthetics launches Skin Quality Index - TipRanks
Iron Triangle Partners LP Has $46.38 Million Position in AbbVie Inc. $ABBV - MarketBeat
Allergan Aesthetics Redefines Skin Quality Communication with Launch of Skin Quality Index - AbbVie News Center
Hamilton Wealth LLC Makes New $4.92 Million Investment in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Fayez Sarofim & Co - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Focus Partners Wealth - MarketBeat
Fred Alger Management LLC Acquires 54,335 Shares of AbbVie Inc. $ABBV - MarketBeat
Elevation Point Wealth Partners LLC Buys 8,652 Shares of AbbVie Inc. $ABBV - MarketBeat
Brevan Howard Capital Management LP Sells 26,408 Shares of AbbVie Inc. $ABBV - MarketBeat
Assessing AbbVie (ABBV) Valuation After Recent Share Price Weakness - simplywall.st
Is AbbVie Inc. (ABBV) a good stock to buy now? - MSN
Is AbbVie Inc. (ABBV) A Good Stock to Buy Now? - Insider Monkey
0.27%
1.08%
자본화:
|
볼륨(24시간):